Z

Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267

Watchlist Manager
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Watchlist
Price: 8.37 CNY 0.72%
Market Cap: 9.8B CNY
Have any thoughts about
Zhejiang Hisun Pharmaceutical Co Ltd?
Write Note

Zhejiang Hisun Pharmaceutical Co Ltd
Investor Relations

Zhejiang Hisun Pharmaceutical Co., Ltd. unfolds its story in the competitive arena of China's booming pharmaceutical industry. Founded in 1956, Hisun has gradually matured from a regional player into a recognized name in global generic and specialty drug manufacturing. The company's core strength lies in its integration across the pharmaceutical supply chain, which allows it to produce active pharmaceutical ingredients (APIs) while also scaling up to final dosage forms. Hisun capitalizes on its robust research and development capabilities, investing heavily in innovation to expand its diverse pharmaceutical product portfolio. Through strategic partnerships and collaborative ventures, such as alliances with leading biotech firms, Hisun not only enhances its technological footprint but fortifies its international presence, poised to address the increasing global demand for affordable healthcare solutions.

In the sprawling marketplace, Hisun’s financial model is driven by its synergistic blend of producing generic medications and investing in biopharmaceuticals. The firm enjoys a lucrative revenue stream by tapping into the cost-effective production of APIs, which are integral to numerous medications worldwide. Through vertically integrated operations, the company achieves economies of scale, facilitating competitive pricing. Hisun’s foray into more value-added, complex generics and biosimilars further diversifies its income channels, transforming challenges into opportunities amid stringent global regulatory landscapes. By navigating these complexities, Hisun strengthens its market position, leveraging a balance between solid internal growth and strategic global outreach, thus sustaining its journey within the dynamic panorama of the pharmaceutical sector.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Weihong Xiao
Chief Executive Officer
No Bio Available
Mr. Zhiqing Yang
Senior Vice President
No Bio Available
Mr. Jiaqiu Du
Director and Senior Vice President
No Bio Available
Mr. Xi Fei Shen Ph.D.
Secretary of the Board
No Bio Available

Contacts

Address
ZHEJIANG
Taizhou
No. 46, Waisha Road, Jiaojiang District
Contacts
+8657185278141
www.hisunpharm.com